Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer

Author:

Kuo Sung-Hsin1234,Yang Shi-Yi5,You San-Lin67,Lien Huang-Chun8,Lin Ching-Hung13,Lin Po-Han9,Huang Chiun-Sheng10

Affiliation:

1. Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

2. Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan

3. Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan

4. National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Taiwan

5. Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan

6. School of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei, Taiwan

7. Big Data Research Center, Fu-Jen Catholic University, New Taipei, Taiwan

8. Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

9. Department of Medical Genetics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

10. Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3